Bildung, Kristallstruktur und absolute Konfiguration von (-)-N-(Chloromethyl)galanthaminium-chlorid = Formation, X-Ray crystal structure, and absolute configuration of (-)-N-(chloromethyl)galanthaminium chlorideMATUSCH, R; KREH, M; MÜLLER, U et al.Helvetica chimica acta. 1994, Vol 77, Num 6, pp 1611-1615, issn 0018-019XArticle

Galantamine : Mortalité accrue = Galantamine : Increased mortalityLa Revue Prescrire. 2005, Vol 25, Num 259, issn 0247-7750, p. 197Article

STEREOCHEMICAL STUDIES. LIV: A BIOGENETIC-TYPE ASYMMETRIC SYNTHESIS OF OPTICALLY ACTIVE GALANTHAMINE FROM L-TYROSINESHIMIZU K; TOMIOKA K; YAMADA SI et al.1978; CHEM. PHARM. BULL.; JPN; DA. 1978; VOL. 26; NO 12; PP. 3765-3771; BIBL. 21 REF.Article

TOTAL SYNTHESIS OF DL-LYCORAMINE.SCHULTZ AG; YEE YK; BERGER MH et al.1977; J. AMER. CHEM. SOC.; U.S.A.; DA. 1977; VOL. 99; NO 24; PP. 8065-8067; BIBL. 16 REF.Article

Effect of galantamine hydrobromide in chronic fatigue syndrome: A randomized controlled trialBLACKER, C. V; GREENWOOD, David T; WESNES, Keith A et al.JAMA, the journal of the American Medical Association. 2004, Vol 292, Num 10, pp 1195-1204, issn 0098-7484, 10 p.Article

Reduction of voluntary ethanol consumption in alcohol-preferring Alko alcohol (AA) rats by desoxypeganine and galanthamineDOETKOTTE, Roman; OPITZ, Klaus; KIIANMAA, Kalervo et al.European journal of pharmacology. 2005, Vol 522, Num 1-3, pp 72-77, issn 0014-2999, 6 p.Article

Galantamine for the Treatment of Cognitive Impairments in People With SchizophreniaBUCHANAN, Robert W; CONLEY, Robert R; DICKINSON, Dwight et al.The American journal of psychiatry. 2008, Vol 165, Num 1, pp 82-89, issn 0002-953X, 8 p.Article

Mixed-effect circadian rhythm model for human erythrocyte acetylcholinesterase activity—application to the proof of concept of cholinesterase inhibition by acorn extract in healthy subjects with galantamine as positive controlSEUNGHOON HAN; LEE, Jongtae; JEON, Sangil et al.European journal of clinical pharmacology. 2012, Vol 68, Num 5, pp 599-605, issn 0031-6970, 7 p.Article

Simultaneous determination of antidementia drugs in human plasma: Procedure transfer from HPLC―MS to UPLC―MS/MSNOETZLI, Muriel; ANSERMOT, Nicolas; DOBRINAS, Maria et al.Journal of pharmaceutical and biomedical analysis. 2012, Vol 64-65, pp 16-25, issn 0731-7085, 10 p.Article

Gingko biloba extract EGb 761^®: clinical data in dementiaIHL, Ralf.International psychogeriatrics. 2012, Vol 24, issn 1041-6102, S35-S40, SUP1Article

Switching cholinesterase inhibitors in older adults with dementiaMASSOUD, Fadi; DESMARAIS, Julie Eve; GAUTHIER, Serge et al.International psychogeriatrics. 2011, Vol 23, Num 3, pp 372-378, issn 1041-6102, 7 p.Article

Synthesis, spectral characterization and biological evaluation of phosphorylated derivatives of galanthamineKOTESWARA RAO, V; JANARDHAN RAO, A; SUBBA REDDY, S et al.European journal of medicinal chemistry. 2010, Vol 45, Num 1, pp 203-209, issn 0223-5234, 7 p.Article

New Prospectives in the Delivery of Galantamine for Elderly Patients Using the IntelliDrug Intraoral Device: In Vivo Animal StudiesGIANNOLA, L. I; PADERNI, C; DE CARO, V et al.Current pharmaceutical design (Print). 2010, Vol 16, Num 6, pp 653-659, issn 1381-6128, 7 p.Article

Early and Differential Diagnosis of Dementia and Mild Cognitive Impairment: Design and Cohort Baseline Characteristics of the German Dementia Competence NetworkKORNHUBER, Johannes; SCHMIDTKE, Klaus; JAHN, Holger et al.Dementia and geriatric cognitive disorders. 2009, Vol 27, Num 5, pp 404-417, issn 1420-8008, 14 p.Article

Optimal Dosing of Galantamine in Patients with Mild or Moderate Alzheimer's Disease: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled TrialARONSON, Stephen; VAN BAELEN, Bart; KAVANAGH, Shane et al.Drugs & aging. 2009, Vol 26, Num 3, pp 231-239, issn 1170-229X, 9 p.Article

Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamineRODDA, Joanne; MORGAN, Shirlony; WALKER, Zuzana et al.International psychogeriatrics. 2009, Vol 21, Num 5, pp 813-824, issn 1041-6102, 12 p.Article

A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depressionHOLTZHEIMER, Paul E; MEEKS, Thomas W; BYRD, Eve H et al.International journal of geriatric psychiatry. 2008, Vol 23, Num 6, pp 625-631, issn 0885-6230, 7 p.Article

Decreased initiation of usual activities in people with mild-to-moderate Alzheimer's disease : a descriptive analysis from the VISTA clinical trialCOOK, Cheryl; FAY, Sherri; ROCKWOOD, Kenneth et al.International psychogeriatrics. 2008, Vol 20, Num 5, pp 952-963, issn 1041-6102, 12 p.Article

A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophreniaLEE, Sae-Woom; LEE, Jung-Goo; LEE, Bong-Ju et al.International clinical psychopharmacology. 2007, Vol 22, Num 2, pp 63-68, issn 0268-1315, 6 p.Article

The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid_25-35 I.c.v.-injected mice : Involvement of dopaminergic systemsDAYONG WANG; NODA, Yukihiro; YUAN ZHOU et al.Neuropsychopharmacology (New York, NY). 2007, Vol 32, Num 6, pp 1261-1271, issn 0893-133X, 11 p.Article

Galantamine improves cognition in schizophrenic patients stabilized on risperidoneSCHUBERT, Max H; YOUNG, Keith A; HICKS, Paul B et al.Biological psychiatry (1969). 2006, Vol 60, Num 6, pp 530-533, issn 0006-3223, 4 p.Article

A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder : A pilot studyBIEDERMAN, Joseph; MICK, Eric; FARAONE, Stephen et al.Journal of clinical psychopharmacology. 2006, Vol 26, Num 2, pp 163-166, issn 0271-0749, 4 p.Article

Beneficial effects of galantamine on performance in the object recognition task in Swiss mice : Deficits induced by scopolamine and by prolonging the retention intervalDE BRUIN, Natasja; POUZET, Bruno.Pharmacology, biochemistry and behavior. 2006, Vol 85, Num 1, pp 253-260, issn 0091-3057, 8 p.Article

Choline pivaloyl ester strengthened the benefit effects of Tacrine and Galantamine on electroencephalographic and cognitive performances in nucleus basalis magnocellularis-lesioned and aged ratsRISPOLI, V; MARRA, R; COSTA, N et al.Pharmacology, biochemistry and behavior. 2006, Vol 84, Num 3, pp 453-467, issn 0091-3057, 15 p.Article

Effect of galantamine on the human α7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activityTEXIDO, Laura; ROS, Esteve; MARTIN-SATUE, Mireia et al.British journal of pharmacology. 2005, Vol 145, Num 5, pp 672-678, issn 0007-1188, 7 p.Article